RGLS Feb 2025 4.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 12:01PM EDT. Market open.
| Previous close | 0.3500 |
| Open | 0.4000 |
| Bid | 0.0000 |
| Ask | 4.8000 |
| Strike | 4.00 |
| Expiry date | 2025-02-21 |
| Day's range | 0.3500 - 0.4000 |
| Contract range | N/A |
| Volume | |
| Open interest | 32 |
PR NewswireRegulus Therapeutics Announces Participation at Two Healthcare Investment Conferences
Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (the "Company" or "Regulus"), today announced that the Company will participate in the following investor conferences:
Simply Wall St.Companies Like Regulus Therapeutics (NASDAQ:RGLS) Are In A Position To Invest In Growth
Just because a business does not make any money, does not mean that the stock will go down. For example, although...
- Associated Press Finance
Regulus: Q2 Earnings Snapshot
SAN DIEGO (AP) — Regulus Therapeutics Inc. RGLS) on Thursday reported a loss of $11 million in its second quarter. On a per-share basis, the San Diego-based company said it had a loss of 17 cents.
© 2024 Yahoo. All rights reserved.